Onemednet Corp (ONMD) Stock Analysis
Verdict: AVOID
Heavy insider buying and a new $11.5M AI contract offer a speculative floor, but negative gross margins and liquidity risk remain extreme.
Investment score: 38/100
Analysis as of
Is Onemednet Corp stock worth reviewing? The TradeMates thesis
Speculative hold based on major contract win vs. severe insolvency risk.
7-factor investment score
- Valuation: 20/100 (weight 20%)
- Financial Health: 10/100 (weight 15%)
- Technical Momentum: 45/100 (weight 15%)
- Earnings Quality: 25/100 (weight 15%)
- Insider Sentiment: 90/100 (weight 10%)
- Analyst Consensus: 50/100 (weight 10%)
- Risk-Adjusted Return: 30/100 (weight 15%)
Onemednet Corp opportunities and risks
What speaks for ONMD
- $11.5M AI Training Agreement
What speaks against ONMD
- Terminal Dilution Risk
Peers and competitors
- CRW.L
- OPT.L
- PTRK.ST
- DOC.AX
- COG.L
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| ONMD | n/a | 30.6x | n/a | -51.4% | -254.1% | -17.6% |
| CRW.L | 26.0x | 2.6x | 11.5x | 78.0% | 10.6% | 1.7% |
| OPT.L | 59.2x | 1.8x | 13.4x | 21.5% | 3.1% | 3.8% |
| COG.L | n/a | 1.6x | n/a | 74.5% | -17.8% | -0.4% |
| Peer median | 26.0x | 1.8x | 11.5x | 74.5% | 3.1% | 1.7% |
Frequently asked questions about Onemednet Corp (ONMD)
Is ONMD stock a good investment?
The TradeMates model rates Onemednet Corp as AVOID with an investment score of 38/100. Speculative hold based on major contract win vs. severe insolvency risk. This is algorithmic model output, not personal investment advice.
Is ONMD stock a buy?
The TradeMates model verdict for ONMD is AVOID with an investment score of 38/100. Treat this as a model signal to review, not a personal buy recommendation.